60-Day FRN

64476

Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices

proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Factors Influencing the Transmission
of Influenza (OMB Control No. 0920–
0888, Exp. 2/28/2021)—Extension—
National Institute for Occupational
Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The National Institute for
Occupational Safety and Health
(NIOSH) is authorized to conduct
research to advance the health and
safety of workers under Section 20(a)(1)
of the 1970 Occupational Safety and
Health Act. NIOSH is requesting an
extension to an existing ICR (expiring
February 28, 2021) because the ongoing

will be collected and tested for
influenza virus, and the levels of
influenza infection-associated
biomarkers will be measured in blood
samples from these subjects.
Volunteer adult participants will be
recruited by a test coordinator using a
poster and flyers describing the study.
Interested potential participants will be
screened verbally to verify that they
have influenza-like symptoms and that
they do not have any medical
conditions that would preclude their
participation. A matching number of
healthy control participants will also be
recruited. Qualified participants who
agree to participate in the study will be
asked to read and sign an informed
consent form, and then to complete a
short health questionnaire. After
completing the forms, the participant’s
oral temperature will be measured, and
two nasopharyngeal mucus samples and
five ml of blood will be collected. The
participant then will be asked to don an
elastomeric mask and breathe and cough
normally for 40 minutes into an aerosol
particle collection system. The total
time from initial verbal screening to
completion will be about 95 minutes.
The study will require 90 volunteer test
subjects each year for three years, for a
total of 270 test participants. There are
no costs to respondents other than their
time.

COVID–19 pandemic has temporarily
halted the study due to staff safety
concerns and an inability to access
healthcare facilities in order to recruit
test subjects.
Influenza continues to be a major
public health concern because of the
substantial health burden from seasonal
influenza and the potential for a severe
pandemic. Although influenza is known
to be transmitted by infectious
secretions, these secretions can be
transferred from person to person in
many different ways, and the relative
importance of the different pathways is
not known. The likelihood of the
transmission of influenza virus by small
infectious airborne particles produced
during coughing and breathing is
particularly unclear. The question of
airborne transmission is especially
important in healthcare facilities, where
influenza patients tend to congregate
during influenza season, because it
directly impacts the infection control
and personal protective measures that
should be taken by healthcare workers.
The purpose of this study is to gain
a better understanding of the production
of infectious aerosols by patients with
influenza, and to compare this to the
levels of biomarkers of influenza
infection in the blood of these patients.
To do this, airborne particles produced
by volunteer subjects with influenza

ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents

Potential participant
Qualified participant
Qualified participant
Qualified participant

Number of
responses per
respondent

Average
burden per
response
(in hrs.)

Total burden
(in hrs.)

..........................
..........................
..........................
..........................

Initial verbal screening .....................
Informed consent form .....................
Health questionnaire ........................
Medical testing .................................

180
90
90
90

1
1
1
1

3/60
15/60
5/60
72/60

9
23
8
108

Total ...........................................

...........................................................

........................

........................

........................

148

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–22489 Filed 10–9–20; 8:45 am]
BILLING CODE 4163–18–P

khammond on DSKJM1Z7X2PROD with NOTICES

Number of
respondents

Form name

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1243; Docket No. CDC–2020–
0105]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of

SUMMARY:

VerDate Sep<11>2014

18:52 Oct 09, 2020

Jkt 253001

PO 00000

Frm 00036

Fmt 4703

Sfmt 4703

its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection entitled ‘‘Rapid Response
Suicide Investigation Data Collection.’’
CDC will use the information collected
to continue providing rapid responses to
urgent requests for CDC assistance in
the investigation of an apparent or
unexplained potential cluster or
increase in suicidal behavior.

E:\FR\FM\13OCN1.SGM

13OCN1

64477

Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices
Written comments must be
received on or before December 14,
2020.

DATES:

You may submit comments,
identified by Docket No. CDC–2020–
0105 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
ADDRESSES:

leaders; schools; or other partner
organizations) to conduct investigations
of suicide. Supporting rapid
investigations to inform the
implementation of effective suicide
prevention strategies is one of the most
important ways CDC can serve to
protect and promote the health of the
public.

previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.

Rapid Response Suicide Investigation
Data Collections are specifically
designed to inform the implementation
of prevention strategies in a state,
county, community, or vulnerable
population where a possible suicide
cluster or increasing trend has been
observed. This generic clearance will
not be used to conduct research studies
or to collect data designed to draw
conclusions about the United States or
areas beyond the defined geographic
location or vulnerable population that is
the focus of the investigation. CDC in
collaboration with external partners
(e.g., local, state, territory, and tribal
health authorities; other federal
agencies; local and state leaders;
schools; or other partner organizations),
will identify the respondent universe for
each Rapid Response Suicide
Investigation Data Collection. The
respondent universe will be determined
based on the information needed to
understand potential suicide clusters,
significant increases in suicidal
behavior and suicide, risk and
protective factors, and vulnerable
populations in order to inform the
implementation of suicide prevention
strategies. When the goal is
generalizability, CDC will submit the
sampling methods to OMB as part of the
GenIC package. The estimated annual
burden hours are 1,000. There are no
costs to respondents other than their
time.

Proposed Project
Rapid Response Suicide Investigation
Data Collection (OMB Control No.
0920–1243, Exp. 09/30/2021)—
Extension—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC is frequently called upon to
respond to urgent requests from one or
more external partners (e.g., local, state,
territory, and tribal health authorities;
other federal agencies; local and state

khammond on DSKJM1Z7X2PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Form name

Rapid Response Suicide Investigation Data Collection Participants.

Rapid Response Suicide Investigation Protocol.

Number of
responses per
respondent

2,000

1

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–22493 Filed 10–9–20; 8:45 am]
BILLING CODE 4163–19–P

VerDate Sep<11>2014

18:52 Oct 09, 2020

Jkt 253001

PO 00000

Frm 00037

Fmt 4703

Sfmt 4703

E:\FR\FM\13OCN1.SGM

13OCN1

Average
burden per
response
(in hours)
30/60

Total
burden hours
1,000